Denosumab and Pembrolizumab in Renal Cell Carcinoma: A Phase II Trial

Project: Research

Project Description

NMA HREC Reference Number: HREC/17/RPAH/159
NMA SSA Reference Number: SSA/18/MonH/14
Monash Health Ref: RES-18-0000-017X
StatusActive
Effective start/end date25/03/1924/03/24

Keywords

  • clinical trial
  • phase 2 trial
  • treatment efficacy
  • renal cancer